| Literature DB >> 30320118 |
Vered Hermush1,2, Yitshal Berner3, Yael Katz2,4, Yanina Kunin2,4, Irena Krasniansky2,4, Yael Schwartz1,2, Debbie Mimran Nahon2,4, Ana Elizariev1,2, Gad Mendelson2,4.
Abstract
Background: The use of gastrostomy tubes for long-term nutritional support in older patients is frequent. Percutaneous gastrostomy tube placement may be performed using various techniques, including endoscopic, surgical, and radiologically-guided methods. While percutaneous endoscopic gastrostomy (PEG) placement is the most widely used and accepted approach, experience with the use of percutaneous radiological gastrostomy (PRG) is more limited. Objective: To evaluate the safety and short-term outcomes of PRG in older patients requiring long-term enteral feeding. Method: We performed a prospective study involving all patients aged 65 years and older who underwent PRG insertion at the Laniado hospital over a period of 2 years. Adverse events related to the gastrostomy tube insertion were recorded over a period of 3 months following the procedure.Entities:
Keywords: elderly; enteral nutrition; feeding tube; percutaneous radiological gastrostomy; survival
Year: 2018 PMID: 30320118 PMCID: PMC6168734 DOI: 10.3389/fmed.2018.00274
Source DB: PubMed Journal: Front Med (Lausanne) ISSN: 2296-858X
Figure 1Percutaneous radiological gastrostomy tube insertion.
Figure 2A schematic description of the percutaneous radiological gastrostomy procedure.
General characteristics of the study patients N = 58.
| Age (years) | 78.12 ± 11.45 |
| Female | 28 (48%) |
| Dementia | 24 (41%) |
| CVA | 27 (47%) |
| Pulmonary diseases | 7 (12%) |
| Mechanical ventilation | 22 (38%) |
| DM | 11 (19%) |
| Renal failure | 3 (5%) |
| MNA-SF | 5.80 ± 2.56 |
| BMI | 24.39 ± 5.35 |
| Albumin g/dL | 3.17 ± 0.53 |
| Hemoglobin g/dL | 10.67 ± 1.83 |
| WBC | 9.96 ± 3.18 |
CVA, cerebrovascularaccident,
DM, diabetesmellitus,
MNA-SF, Mini-NutritionalAssessmentshort-form,
BMI, bodymassindex,
WBC, whitebloodcells.
Adverse events of the study patients during a 3-month follow-up period N = 58.
| Death | 2 (3%) | 3 (5%) | 4 (7%) |
| Peritonitis | 2 (3%) | 1 (2%) | |
| Aspiration | 2 (3%) | 1 (2%) | 2 (3%) |
| Local infection | 20 (35%) | 11 (19%) | 8 (14%) |
| Tube dislodgement | 2 (3%) | 7 (12%) | 8 (14%) |
Changes in laboratory data over a 3-month period of follow-up.
| BMI* kg/m2 | 0.13 ± 4.07 |
| Albumin g/dL | 0.16 ± 0.47 |
| Hemoglobin g/dL | 0.34 ± 1.13 |
| WBC | 0.43 ± 3.61 |
BMI, body mass index,
WBC, white blood cells.